Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: J Subst Abuse Treat. 2011 Nov 25;43(1):94–107. doi: 10.1016/j.jsat.2011.09.016

Table 4.

Means (SD) and Treatment Effects on Secondary Health Outcomes

Assessment Time-point Average Raw Score Linear Mixed Model
Outcome (Instrument) Month MABT (SD) TAU (SD) β F P
Psychological Symptoms
Eating Disorder Symptoms (EDE-Q) BL 1.4 (0.61)
(n=31)*
1.7 (0.61)
(n=15)*
3mo 1.3 (0.6)
(n=24)*
1.6 (0.64)
(n=11)
−0.26 1.38 0.24
6mo 1.0 (0.53)
(n=22)*
2.3 (0.7)
(n=12)*
−0.66 7.24 0.01
9mo 1.1 (0.53)
(n=24)*
2.5 (0.75)
(n=11)*
−0.80 7.61 0.01
Depression (BSI) BL 2.4 (0.34) 2.2 (0.43)
3mo 1.1 (0.55) 1.1 (0.48) −0.24 0.38 0.54
6mo .79 (0.5) 1.5 (0.56) −1.01 5.76 0.02
9mo . 90 (0.54) 1.8 (0.69) −1.11 6.10 0.02
Anxiety (BSI) BL 2.0 (0.34) 1.8 (0.45)
3mo 1.1 (0.46) 1.1 (0.46) −0.08 0.08 0.77
6mo .64 (0.46) 1.21 (0.38) −0.81 5.99 0.02
9mo .85 (0.5) 1.4 (0.61) −0.60 2.38 0.13
PTSD Symptoms (MPSS) BL 57 (2.55) 48 (2.35)
3mo 32 (2.3) 40 (2.85) −0.35 1.50 0.22
6mo 24 (2.83) 32 (2.61) −0.48 2.27 0.14
9mo 25 (2.64) 37 (3.66) −0.40 1.29 0.26
Physical Symptoms and Pain
Physical Symptoms (MED) BL 15 (6.11) 15 (6.08)
3mo 12 (5.76) 12 (5.8) 0.10 0.32 0.58
6mo 11 (7.68) 13 (5.81) 0.15 0.59 0.45
9mo 10 (6.45) 14 (5.61) −0.25 1.02 0.31
Physical Symptom Frequency (MED) BL 3.6 (1.23) 3.6 (1.08)
3mo 2.9 (0.94) 3.3 (1.03) −0.32 1.15 0.29
6mo 3.29 (1.31) 3.4 (0.58) −0.14 0.21 0.65
9mo 3.0 (1.3) 3.8 (1.14) −0.69 5.24 0.03
Pain Score (VAS) BL 45 (22.04) 42 (25.93)
3mo 37 (18.61) 43 (23.57) −0.27 1.17 0.28
6mo 33 (25.89) 38 (21.44) −0.25 0.79 0.38
9mo 30 (25.6) 46 (22.99) −0.57 2.61 0.11
Coping Indicators
Dissociation Experiences (DES) BL 13 (1.17) 12 (1.61)
3mo 10 (1.2) 16 (1.82) −0.70 6.95 0.01
6mo 7.8 (1.23) 13 (1.34) −0.71 6.64 0.01
9mo 6.0 (1.17) 15 (2.07) −0.95 9.72 0.00
Perceived Stress (PSS) BL 11 (2.9) 12 (2.58)
3mo 5.6 (3.36) 7.2 (2.89) −0.58 2.50 0.12
6mo 5.1 (3.58) 7.18 (3.9) −0.63 2.26 0.14
9mo 5.0 (3.24) 8.0 (3.71) −1.03 4.22 0.04
Positive Affect (PANAS) BL 24 (6.78) 24 (7.87)
3mo 35 (8.87) 34 (8.33) 0.20 0.31 0.58
6mo 36 (9.32) 31 (10.16) 0.39 0.86 0.36
9mo 35 (9.79) 28 (10.91) 0.55 1.27 0.26
Negative Affect (PANAS) BL 34 (7.84) 36 (8.22)
3mo 21 (7.2) 25 (8.36) −0.21 0.52 0.47
6mo 19 (6.45) 23 (8.43) −0.18 0.30 0.58
9mo 20 (8.36) 25 (9.06) −0.45 1.32 0.25
Control Difficulties (DERS) BL 15 (0.93) 12 (0.39)
3mo 8.7 (0.5) 9.8 (0.54) −0.43 3.68 0.06
6mo 7.3 (0.36) 10 (0.72) −0.55 5.82 0.02
9mo 8.4 (0.57) 10 (0.60) −0.45 3.15 0.08
Limited Strategies (DERS) BL 22 (0.76) 19 (0.66)
3mo 14 (0.67) 15 (0.66) −0.44 2.53 0.12
6mo 13 (0.6) 17 (0.83) −0.70 5.05 0.03
9mo 14 (0.66) 18 (0.86) −0.63 2.78 0.10
Lack of Clarity (DERS) BL 14 (0.58) 14 (0.69)
3mo 11(0.56) 12 (0.50) −0.15 0.33 0.57
6mo 10 (0.48) 12 (0.62) −0.20 0.41 0.52
9mo 19 (0.58) 12 (0.75) −0.37 0.94 0.34
MABT Process Variables
Bodily Dissociation (SBC) BL 1.6 (0.69) 1.6 (0.67)
3mo 1.2 (0.64) 1.1 (0.29) 0.08 0.10 0.75
6mo .94 (0.47) 1.3 (0.53) −0.47 3.53 0.06
9mo 0.88 (0.39) 1.4 (0.61) −0.70 6.60 0.01
Body Investment (BIS) BL 7.5 (1) 7.5 (1.1)
3mo 7.7 (1.1) 7.6 (.92) 0.05 0.03 0.85
6mo 7.7 (1.3) 7.6 (1.0) 0.20 0.40 0.53
9mo 8.0 (1.1) 7.3 (1.1) 0.70 3.79 0.06
Body Awareness (SBC) BL 2.4 (0.6) 2.5 (0.59)
3mo 2.6 (0.66) 2.6 (0.81) 0.05 0.02 0.88
6mo 2.5 (0.67) 2.4 (0.71) 0.30 0.82 0.37
9mo 2.5 (0.65) 2.4 (0.52) 0.21 0.30 0.59
Mindfulness Skills (5FFMQ) BL 116 (23.98) 122 (22.79)
3mo 135 (24.76) 129 (17.14) 0.26 0.94 0.33
6mo 139 (22.29) 130 (22.49) 0.33 1.26 0.27
9mo 139 (23.9) 131 (19.34) 0.23 0.46 0.50

BL = Baseline;

*

the sample size for MABT and TAU at each time-point for all measures

Note: MABT and TAU were comparable on all measures at baseline.